SCHEMBL4266558

SCHEMBL4266558

COc1ccc(-c2c3nc(cc4ccc([nH]4)c(-c4ccc(OC)cc4)c4nc(cc5ccc2[nH]5)C=C4)C=C3)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STAT3 P40763 1/20 0.63
▸ STAT1 P42224 1/20 0.63
▸ ABCG2 Q9UNQ0 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ TERT O14746 2/20 0.40
▸ MAPT P10636 1/20 0.40
▸ CASP3 P42574 1/20 0.40
▸ SENP8 Q96LD8 1/20 0.40
▸ SENP7 Q9BQF6 1/20 0.40
▸ SENP6 Q9GZR1 1/20 0.40
▸ TOP1 P11387 4/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ CYCS P99999 3/20 0.39
▸ SLC2A1 P11166 1/20 0.39
▸ ENPP2 Q13822 1/20 0.38
▸ AURKA O14965 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9590030 0.97 STAT3 (0.60) STAT3STAT1ABCG2KDM4ENPC1
SCHEMBL8996959 0.96 STAT3 (0.59) STAT3STAT1ABCG2KDM4ENPC1
SCHEMBL7257328 0.94 STAT3 (0.56) STAT3STAT1ABCG2KDM4ENPC1
SCHEMBL5011955 0.93 STAT3 (0.55) STAT3STAT1ABCG2KDM4ENPC1
SCHEMBL3838362 0.92 STAT3 (0.54) STAT3STAT1ABCG2KDM4ENPC1
SCHEMBL8431348 0.92 STAT3 (0.54) STAT3STAT1ABCG2KDM4ENPC1
SCHEMBL6804332 0.89 STAT3 (0.59) STAT3STAT1ABCG2KDM4ENPC1
SCHEMBL7258044 0.87 STAT3 (0.49) STAT3STAT1ABCG2KDM4EMAPT
SCHEMBL2942315 0.87 STAT3 (0.56) STAT3STAT1ABCG2KDM4ENPC1
SCHEMBL28890811 0.86 STAT3 (0.60) STAT3STAT1KDM4ENPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190331661-A1 CHEMICAL SENSORS WITH NON-COVALENT, ELECTROSTATIC SURFACE MODIFICATION OF GRAPHENE REGENTS OF THE UNIVERSITY OF MINNESOTA 2019-10-31 — — US disclosed
US-7521551-B2 Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy MIRAVANT PHARMACEUTICALS, INC. (US) 2009-04-21 — — US disclosed
US-20080275232-A1 CHLORINS POSSESSING FUSED RING SYSTEMS USEFUL AS PHOTOSELECTIVE COMPOUNDS FOR PHOTODYNAMIC THERAPY MIRAVANT PHARMACEUTICALS, INC. 2008-11-06 — — US disclosed
US-20050020560-A1 Chlorins processing fused ring systems useful as photoselective compounds for photodynamic therapy MIRAVANT PHARMACEUTICALS, INC. 2005-01-27 — — US disclosed
US-6794505-B1 Chlorins possessing fused ring systems useful as photoselective compounds for photodynamic therapy MIRAVANT PHARMACEUTICALS, INC. 2004-09-21 — — US disclosed
WO-2001074818-A1 CHLORINS WITH FUSED RINGS FOR USE IN PHOTODYNAMIC THERAPY MIRAVANT PHARMACEUTICALS, INC. (US) 2001-10-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275232-A1 CHLORINS POSSESSING FUSED RING SYSTEMS USEFUL AS PHOTOSELECTIVE COMPOUNDS FOR PHOTODYNAMIC THERAPY PPOX, HMBS, DDT STAT3 3696/4885STAT1 3561/4885ABCG2 1576/4885
US-20050020560-A1 Chlorins processing fused ring systems useful as photoselective compounds for photodynamic therapy PPOX, HMBS, DDT STAT3 3916/4885STAT1 3672/4885ABCG2 1953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback